{"database": "lobbying", "table": "lobbying_activities", "rows": [[1690143, "66826d6c-abfa-4f9d-9dbf-8d2be188813a", "Q2", "THE CORMAC GROUP, LLC", 66773, "HTG MOLECULAR DIAGNOSTICS, INC.", 2015, "second_quarter", "MED", "Medicare high end technology reimbursement issues", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2015-07-01T14:09:46.933000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1690143"], "units": {}, "query_ms": 68.69533890858293, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}